2020
DOI: 10.1159/000508358
|View full text |Cite
|
Sign up to set email alerts
|

Metastatic Ovarian Cancer Presenting as Inflammatory Breast Cancer: A Case Report

Abstract: Metastatic ovarian cancer to the breast is a rare presentation, with limited cases reported worldwide. Common sites for distant metastasis in ovarian cancer are to the liver, lung, and pleura [Dauplat et al. Cancer. 1987 Oct 1;60(7):1561-6]. Usually, such cases predict poor prognosis with troublesome management. We present one challenging case of a 54-year-old female patient with recurrent clear cell ovarian cancer, presenting with right breast mass of primary versus secondary origin, progressing into inflamma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(10 citation statements)
references
References 20 publications
0
10
0
Order By: Relevance
“…The table provided below summarizes current cases in the existing literature that describe the treatment, time to recurrence, and prognosis of ovarian cancer patients with breast metastases (Table 1 ). 8 cases implemented systemic chemotherapy in their initial treatment of metastatic ovarian carcinoma to the breast, and one case added adjunctive local radiation to their treatment regimen [ 8 ]. Three cases included surgical management in their initial treatment, with two of those cases having surgical management before initiation of chemotherapy for suspected primary breast cancer [ 11 , 12 ] and the other case performing surgery for palliative treatment [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The table provided below summarizes current cases in the existing literature that describe the treatment, time to recurrence, and prognosis of ovarian cancer patients with breast metastases (Table 1 ). 8 cases implemented systemic chemotherapy in their initial treatment of metastatic ovarian carcinoma to the breast, and one case added adjunctive local radiation to their treatment regimen [ 8 ]. Three cases included surgical management in their initial treatment, with two of those cases having surgical management before initiation of chemotherapy for suspected primary breast cancer [ 11 , 12 ] and the other case performing surgery for palliative treatment [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…2020 [ 7 ] 53 2 years Chemotherapy Yes 2 months Local radiation (3500 Gy) Chemotherapy 36 months (death) Abu-Tineh et al . [ 8 ] 54 14 months Chemotherapy Local radiation (3000 cGy) 24 months (ATP) Wang et al . 2020 [ 9 ] 40 6 years Chemotherapy 4 months (LTF)** Antuono et al .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The appearance of the ovarian metastases to the breast can occur concomitantly with the diagnosis, or up to 16 years following diagnosis, with an average time of two years postdiagnosis. In 11-30% of cases, the metastasis is the first manifestation of malignancy, with the patients then surviving being between 13 days and 85 months [ 2 5 ]. In the case of our patient, the breast metastasis was identified approximately 570 days after her ovarian cancer diagnosis, and she died 79 days after the initial diagnosis of her ovary to breast metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…Papillary serous adenocarcinomas are the most frequent ovarian cancers to metastasize to the breast and often present as discreet breast lesions [ 2 4 ]. Interestingly, a small subset of these metastases has clinically presented as very rare inflammatory breast cancers, with 12 documented cases [ 5 ]. Here, we report an unusual case of a high-grade ovarian serous adenocarcinoma presenting as inflammatory breast cancer.…”
Section: Introductionmentioning
confidence: 99%